PT - JOURNAL ARTICLE AU - Khalid, Sumaira AU - Innes, Kim E. AU - Umer, Amna AU - Lilly, Christa AU - Gross, Diane AU - Sambamoorthi, Usha TI - Assessment of Joint and Interactive Effects of Multimorbidity and Chronic Pain on ADRD Risk in the Elder Population AID - 10.1101/2022.08.02.22278338 DP - 2022 Jan 01 TA - medRxiv PG - 2022.08.02.22278338 4099 - http://medrxiv.org/content/early/2022/08/03/2022.08.02.22278338.short 4100 - http://medrxiv.org/content/early/2022/08/03/2022.08.02.22278338.full AB - Objective Multimorbidity and non-cancer chronic pain conditions (NCPC) are independently linked to elevated risk for cognitive impairment and incident Alzheimer’s Disease and Related Dementias (ADRD)-both - We present the study of potential joint and interactive effects of these conditions on the risk of incident ADRD in older population.Methods This retrospective-cohort study drew baseline and 2-year follow-up data from linked Medicare claims and Medicare Current Beneficiary Survey (MCBS). Baseline multimorbidity and NCPC were ascertained using claims data. ADRD was ascertained at baseline and follow-up.Results NCPC accompanied by multimorbidity (vs. absence of NCPC or multimorbidity) had a significant and upward association with incident ADRD (adjusted odds ratio (AOR): 1.72, 95% CI 1.38, 2.13, p<0.0001). Secondary analysis by number of comorbid conditions suggested that the joint effects of NCPC and multimorbidity on ADRD risk may increase with rising number contributing chronic conditions. Interaction analyses indicated significantly elevated excess risk for incident ADRD.Competing Interest StatementThe authors have declared no competing interest.Funding Statementthe National Institute of General Medical Sciences of the National Institutes of Health (Award Number 2U54GM104942-02), the WVCTSI and the Alzheimers Research and Prevention Foundation (ARPF).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The present study was determined by the WVU Institutional Review Board (IRB) as not meeting the definition of human subject research due to the deidentified nature of the data used in our analyses (H-22407)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://www.cms.gov/Research-Statistics-Data-and-Systems/Research-Statistics-Data-and-Systems